Kivitz A, Wang L, Alevizos I, et al. The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis. RMD Open 2023;9:e003317. doi: 10.1136/rmdopen-2023-003317
In this article, Figure 4 has been updated to resolve an error.